Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Red Cross aid

More pharma aid sent to Haiti

January 21, 2010 Research and Development, Sales and Marketing Haiti, disaster, relief

A week after the devastating earthquake in Haiti the number pharma companies sending aid to the stricken country continues to …
News
clive-dix

Clive Dix appointed chairman of Crescendo Biologics

January 21, 2010 Research and Development Crescendo Biologics, appointment, research and development

Cambridge, UK-based Crescendo Biologics has appointed Clive Dix as chairman. He will work closely with chief scientific officer Mike Romanos …
Appointment

GSK launches ‘Open Lab’ to share resources

January 21, 2010 Research and Development, Sales and Marketing Africa, GlaxoSmithKline, malaria

GlaxoSmithKline has announced a series of measures to help improve medical treatment in poor countries. It has set up an …
News

FDA to study effects of medication during pregnancy

January 20, 2010 Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …
News

Dr Kai Lindevall re-appointed chief executive of Encorium

January 20, 2010 Research and Development Encorium, appointment, research and development

Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 …
Appointment

Dr Lloyd Payne joins Aquapharm Biodiscovery as research director

January 20, 2010 Research and Development Aquapharm Biodiscovery, appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Dr Lloyd Payne as its new research director. He joins Aquapharm from …
Appointment

University of Cambridge joins Lilly’s open innovation group

January 20, 2010 Research and Development Cambridge University, OIDD, University of Cambridge, lilly

The University of Cambridge is to join Eli Lilly’s ‘Open Innovation Drug Discovery’ project. Lilly first launched its online portal …
News
Boehringer building at night

Boehringer targets ‘genome guardian’ protein for cancer collaboration

January 19, 2010 Research and Development Boehringer, Cancer, Priaxon, genome

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …
News

Contract research news in brief

January 19, 2010 Research and Development Bioanalytical Systems, Charles River Laboratories, Invivodata, Quintiles, ReSearch Pharmaceutical, ReSearch Pharmaceutical Se Invivodata, Synomics Pharma

Our round-up of developments in the world of outsourced R&D includes job losses at Charles River, India’s SIRO Clinpharma buying …
News

Victoza pill trial begins

January 19, 2010 Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
News
ICON Bruce Given

Bruce Given appointed chairman of ICON

January 18, 2010 Research and Development ICON, appointment, research and development

Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …
Appointment
Xceleron's Dr Graham Lappin

Talking R&D: Microdosing studies

January 18, 2010 Research and Development Microdosing, Talking R&D, Xceleron

A microdose study is performed at an early stage of development in order to obtain preliminary pharmacokinetic or distribution data …
Feature
Pfizer

Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010 Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …
News

AstraZeneca taps Korean firm for antibiotics

January 15, 2010 Research and Development Asia, AstraZeneca, CrystalGenomics, Korea, anti-infectives

AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …
News
SWest_2009

MDS promotes Steve West to chief executive

January 14, 2010 Research and Development appointment, mds, research and development

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026